Table 2.
Clinical characteristics in different age groups of ZIKV-infected participants (N = 59).
| Clinical characteristics | ZIKV-infected cases -no. (%) | Age distribution—no. (%) | p-value | |||||
|---|---|---|---|---|---|---|---|---|
| ≤ 15 years (n = 8) | 16‒25 years (n = 7) | 26‒35 years (n = 12) | 36‒45 years (n = 18) | 46‒55 years (n = 9) | ≥ 56 years (n = 5) | |||
| Fever | 42 (71.2) | 7 (87.5) | 6 (85.7) | 10 (83.3) | 9 (50.0) | 7 (77.8) | 3 (60.0) | 0.262 |
| Arthralgia | 32 (54.2) | 0 (0) | 5 (71.4) | 7 (58.3) | 10 (55.6) | 6 (66.7) | 4 (80.0) | 0.022 |
| Conjunctivitis | 13 (22.0) | 0 (0) | 3 (42.9) | 4 (33.3) | 3 (16.7) | 2 (22.2) | 1 (20.0) | 0.370 |
| Rash | 49 (83.1) | 7 (87.5) | 7 (100.0) | 10 (83.3) | 15 (83.3) | 6 (66.7) | 4 (80.0) | 0.713 |
| Myalgia | 23 (39.0) | 0 (0) | 3 (42.9) | 4 (33.3) | 7 (38.9) | 5 (55.6) | 4 (80.0) | 0.061 |
| Vomiting | 3 (5.1) | 1 (12.5) | 0 (0) | 1 (8.3) | 1 (5.6) | 0 (0) | 0 (0) | 0.884 |
| Diarrhea | 2 (3.4) | 0 (0) | 0 (0) | 1 (8.3) | 0 (0) | 0 (0) | 1 (20.0) | 0.193 |
| Headache | 14 (23.7) | 2 (25.0) | 1 (14.3) | 3 (25.0) | 5 (27.8) | 3 (33.3) | 0 (0) | 0.844 |
| Fatigue | 14 (23.7) | 1 (12.5) | 3 (42.9) | 2 (16.7) | 4 (22.2) | 2 (22.2) | 2 (40.0) | 0.707 |
| Sore throat | 8 (13.6) | 1 (12.5) | 3 (42.9) | 1 (8.3) | 1 (5.6) | 2 (22.2) | 0 (0) | 0.185 |
Numbers in bold represent statistically significant p-values.